Clinical Trial Details
Back to clinical trials
View on ClinicalTrials.gov
Phase N/AInterventional
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
Protocol: STUDY00007809NCT: NCT06074666
Overview
The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.
Eligibility
| Ages | 3 Years - 9 Years |
| Sex | All |
| Healthy Volunteers | No |
| Age Groups | Child |
Inclusion Criteria:
- Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
- Parent has primary medication responsibility.
- Pediatric patient aged 3-9 years
- Child on therapy that includes home-based oral anti-cancer medication, such as 6-MP.
- Parent has verbal English or Spanish fluency.
- Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Exclusion Criteria:
- Parent is unwilling or unable to follow protocol requirements
Investigators
SC
Sharon Castellino
